Press releases
- Vita Global Sciences Partners with Veeva to Streamline Clinical Data Management
- Tigermed Advances Clinical Data Management with Veeva Vault EDC
- Veeva to Present at Upcoming Investor Conferences
- Veeva Announces Fiscal 2025 First Quarter Results
- New Veeva Pulse Findings Show Connected Engagement Creates an Advantage as HCP Access Drops
- For the Second Year in a Row, Veeva MedTech Named Best Overall Medtech Software
- Biopharma Leaders Shape the Future of Drug Development at Veeva R&D and Quality Summit Europe
- Veeva Introduces Vault Basics for Biotechs
- Veeva to Release Fiscal 2025 First Quarter Results on May 30, 2024
- Top Biopharma Brands Reach Audiences 10x More Qualified with Veeva Crossix Prime Segments
More ▼
Key statistics
As of last trade, Veeva Systems Inc (0LO3:LSE) traded at 182.83, 12.21% above the 52 week low of 162.94 set on Nov 10, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 182.83 |
Average volume | 582.00 |
---|---|
Shares outstanding | 161.65m |
Free float | 147.19m |
P/E (TTM) | 52.27 |
Market cap | 29.56bn USD |
EPS (TTM) | 3.50 USD |
Data delayed at least 20 minutes, as of Jul 02 2024 19:10 BST.
More ▼